For instance, HDAC inhibitors can increase the growth of Tregs, which are essential for preserving immunological tolerance and lowering inflammation in MS, and block pro-inflammatory cytokines like IL-2. The gene discussed is HDAC9; the disease is myeloid sarcoma.